Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Diabet Med ; 24(5): 486-93, 2007 May.
Article in English | MEDLINE | ID: mdl-17367311

ABSTRACT

AIMS: Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) prevent the progression of diabetic nephropathy (DN). Studies suggest that combination renin-angiotensin-aldosterone system (RAAS)-inhibiting therapy provides additive benefit in DN. However, these studies are small in size. We performed a meta-analysis of studies investigating combination therapy for DN. METHODS: Studies were identified through a search of medline, embase, cinahl and the Cochrane Database. All trials involving combined ACEI and ARB for slowing progression of DN were included. The primary end point was 24-h urinary protein excretion. Blood pressure, serum potassium and glomerular filtration rate (GFR) were secondary end points. RESULTS: In the 10 included trials, 156 patients received ACEI + ARB and 159 received ACEI only. Most studies were 8-12 weeks in duration. Proteinuria was reduced with ACEI + ARB (P = 0.01). This was associated with significant statistical heterogeneity (P = 0.005). ACEI + ARB was associated with a reduction in GFR [3.87 ml/min (7.32-0.42); P = 0.03] and a trend towards an increase in serum creatinine (6.86 micromol/l 95% CI -0.76-13.73; P = 0.09). Potassium was increased by 0.2 (0.08-0.32) mmol/l (P < 0.01) with ACEI + ARB. Systolic and diastolic blood pressure were reduced by 5.2 (2.1-8.4) mmHg (P < 0.01) and 5.3 (2.2-8.4) mmHg (P < 0.01), respectively. CONCLUSIONS: This meta-analysis suggests that ACEI + ARB reduces 24-h proteinuria to a greater extent than ACEI alone. This benefit is associated with small effects on GFR, serum creatinine, potassium and blood pressure. These results should be interpreted cautiously as most of the included studies were of short duration and the few long-term studies (12 months) have not demonstrated benefit.


Subject(s)
Angiotensin II Type 1 Receptor Blockers/therapeutic use , Angiotensin Receptor Antagonists , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Diabetic Nephropathies/drug therapy , Kidney Diseases/prevention & control , Adult , Aged , Diabetic Nephropathies/complications , Drug Therapy, Combination , Female , Humans , Kidney Diseases/etiology , Male , Middle Aged , Receptors, Angiotensin/therapeutic use
2.
J Health Soc Policy ; 13(2): 21-39, 2001.
Article in English | MEDLINE | ID: mdl-11190655

ABSTRACT

As Medicaid moves toward a system of managed care, Aid for Families with Dependent Children (AFDC) recipients often are assigned to an organization that assumes responsibility for managing their annual receipt of health care. This study reports the results of an investigation into the patterns of medical care utilization by AFDC recipients and their children under reformed Medicaid. The issues explored include whether or not medical care utilization patterns vary by race, and if there are identifiable factors that determine the utilization patterns of AFDC recipients and their children. We conclude that racial differences in medical care utilization do exist for AFDC recipients, but not for their children. Policy makers involved in reforming Medicaid should recognize that certain cohorts continue to exhibit undesirable medical care utilization patterns, and implement measures to rectify this situation.


Subject(s)
Aid to Families with Dependent Children/statistics & numerical data , Managed Care Programs/statistics & numerical data , Medicaid/organization & administration , Patient Acceptance of Health Care/statistics & numerical data , Adult , Black or African American/statistics & numerical data , Aid to Families with Dependent Children/organization & administration , Appalachian Region , Child , Demography , Female , Health Care Surveys , Humans , Male , Multivariate Analysis , Poverty , United States , Utilization Review , White People/statistics & numerical data
3.
Health Care Manage Rev ; 24(1): 45-56, 1999.
Article in English | MEDLINE | ID: mdl-10047978

ABSTRACT

Recent marketplace realities and trends have forced health care institutions to adopt strategic orientations that stress a customer focus. Central to such strategic orientations is the effective utilization of service quality practices and philosophies. Toward that end, this research offers health care institutions an affordable methodology. A real-life application of the rapid assessment methodology (RAM) in a health care operational setting is presented. Finally, a framework to guide the implementation of the RAM methodology is outlined and explored.


Subject(s)
Consumer Behavior , Hospital Administration/standards , Program Evaluation/methods , Total Quality Management/methods , Focus Groups , Health Care Sector/trends , Humans , Leadership , Software Design , Southeastern United States
4.
Eur J Cancer ; 28A(4-5): 762-6, 1992.
Article in English | MEDLINE | ID: mdl-1326305

ABSTRACT

Monoclonal antibody (Mab) mediated immunotherapy of brain tumours requires the identification of tumour-restricted cell surface antigens. We have characterised four primitive neuroectodermal tumours, which included pineoblastoma, medulloblastoma and ependymoblastoma cultures, that demonstrated in vitro evidence of malignant behaviour (anchorage-independent growth and nu/nu xenograft tumour formation). The cytogenetic findings ranged from normal G-banded and Q-banded karyotypes through mixed near-diploid/hyperdiploid. These cultures resembled the cell surface immunophenotypic spectrum of malignant gliomas. They were distinguished from normal glia in vitro by the expression of restricted fetal mesenchymal, neuronal, myoblastic, melanocytic, epidermal, chondrocytic, lymphoid and epithelial antigens. Certain antigens appeared sufficiently represented among central nervous system (CNS) neoplasms to afford potential targets for Mab-mediated immunotherapy.


Subject(s)
Central Nervous System Neoplasms/pathology , Glioma/pathology , Neoplasms, Germ Cell and Embryonal/pathology , Adolescent , Antibodies, Monoclonal , Brain Neoplasms/chemistry , Brain Neoplasms/genetics , Brain Neoplasms/pathology , Central Nervous System Neoplasms/chemistry , Central Nervous System Neoplasms/genetics , Cerebellar Neoplasms/chemistry , Cerebellar Neoplasms/genetics , Cerebellar Neoplasms/pathology , Ependymoma/chemistry , Ependymoma/genetics , Ependymoma/pathology , Female , Glioma/chemistry , Glioma/genetics , Humans , Immunohistochemistry , Immunophenotyping , Infant , Karyotyping , Male , Medulloblastoma/chemistry , Medulloblastoma/genetics , Medulloblastoma/pathology , Neoplasms, Germ Cell and Embryonal/chemistry , Neoplasms, Germ Cell and Embryonal/genetics , Pinealoma/chemistry , Pinealoma/genetics , Pinealoma/pathology , Tumor Cells, Cultured
5.
S Afr Med J ; 75(3): 118-9, 1989 Feb 04.
Article in English | MEDLINE | ID: mdl-2493163

ABSTRACT

The prevalence of penicillin-resistant Neisseria gonorrhoeae in black men with acute urethritis at two clinics for sexually transmitted diseases in Port Elizabeth was assessed during the latter half of 1986. Gonococcal aetiology was confirmed in 80% of 290 patients. Penicillinase-production was detected in 4.3% culture-positive cases, while intermediate penicillin resistance was demonstrated in another 28 isolates (13.9%). At least two strains exhibited high-level penicillin resistance without producing beta-lactamase. All isolates tested were susceptible to tetracycline and spectinomycin. The emergence of penicillin-resistant gonococci throughout southern Africa will require new approaches to the treatment of acute urethritis in men.


Subject(s)
Gonorrhea/microbiology , Neisseria gonorrhoeae/drug effects , Penicillin G/pharmacology , Follow-Up Studies , Gonorrhea/drug therapy , Humans , Male , Neisseria gonorrhoeae/isolation & purification , Penicillin G/therapeutic use , Penicillin Resistance , South Africa
6.
S Afr Med J ; 72(12): 868-70, 1987 Dec 19.
Article in English | MEDLINE | ID: mdl-3321485

ABSTRACT

Yersinia enterocolitica infections with a wide spectrum of clinical presentations have been reported in South Africa. An additional 18 cases were encountered in the eastern Cape region during the period May 1982 - December 1984. Y. enterocolitica isolates comprised 1% of 1,634 faecal examinations performed by the Microbiology Department of the South African Institute for Medical Research in Port Elizabeth during this period, compared with isolation rates of 5.1% for shigellae, 3.7% for salmonellae and 1.3% for Campylobacter jejuni. The majority of Y. enterocolitica infections were in children who presented with diarrhoea and only 2 systemic cases were documented. Although more cases were seen in summer there was no distinct seasonal incidence and this may be attributed to the even climatic conditions prevailing in the region.


Subject(s)
Yersinia Infections/epidemiology , Adolescent , Adult , Child , Child, Preschool , Feces/microbiology , Female , Humans , Infant , Male , Microbial Sensitivity Tests , Seasons , South Africa , Yersinia enterocolitica/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...